Search Results - Matthew J. Colombo

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis by April W. Armstrong, Sang Hee Park, Vardhaman Patel, Pierre Nicolas, Wei-Jhih Wang, Matthew J. Colombo, Viktor Chirikov

    Published in Dermatology and Therapy (2024-06-01)
    Get full text
    Article


  2. 2

    P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial by Joseph F Merola, Subhashis Banerjee, Eric Morand, Piotr Leszczyński, Marilyn Pike, Ronald F van Vollenhoven, Coburn Hobar, Kathryn H Dao, Samantha Pomponi, Matthew J Colombo, Ravi Koti, Thomas Wegman

    Published in Lupus Science and Medicine (2024-03-01)
    Article


  3. 3

    Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms by Joseph F. Merola, Philip J. Mease, April W. Armstrong, Vibeke Strand, Thomas Lehman, Stefan Varga, Jiyoon C. Choi, Brandon Becker, Yichen Zhong, Matthew J. Colombo, Diamant Thaçi, Androniki Bili, Alice B. Gottlieb

    Published in Dermatology and Therapy (2025-05-01)
    Get full text
    Article


Search Tools: